Kenvue Inc. Common Stock vs Envista Holdings Corporation Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $18.08 (market cap $34.11B), while Envista Holdings Corporation Common Stock trades at $23.12 (market cap $3.64B). The key difference: Kenvue Inc. Common Stock is far larger — about 9.4× Envista Holdings Corporation Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.73% dividend while Envista Holdings Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kenvue Inc. Common Stock for 1 Days and Envista Holdings Corporation Common Stock for 0 Days on average.
| KVUE | NVST | |
|---|---|---|
Market Cap | $34.11B | $3.64B |
Volume | 27,388,811 | 2,411,697 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $30.26 |
52-Week Low | $14.11 | $18.95 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $41.62B | $4.10B |
Dividend Yield | 4.73% | — |
Signals from Pluang's Aura AI — not financial advice
Kenvue (KVUE) trades at $17.76, down 0.39% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $15.12B in 2025, with a net income margin of 10.76% and a P/E ratio of 20.89. Recent news highlights conditional EU approval for Kimberly-Clark's $40B acquisition of Kenvue, potentially impacting future operations and shareholder returns.
The outlook is mixed, with strong profitability and consistent dividend payments offering stability, but the pending acquisition introduces uncertainty. Risks include integration challenges and market volatility. Analyst consensus is a Hold with a $19.50 price target, suggesting limited near-term upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.
Read more on NVST →